Osteochondral Defects of the Talus Treated by Mesenchymal Stem Cell Implantation--early Results
Overview
Affiliations
The purpose of this study was to present early results of talus cartilage defects treatment with autologous mesenchymal stem cells CD34+ implantation technique. Nine (9) patients were treated, due to IV degree chondromalation (by ICRS). The applied standard procedure included: clinical examination, AP and lateral x-ray, MRI, preoperative, as well as during control examination. The surgical procedure consisted of the defect's debridement, harvesting and fixation of the periosteal flap and CD34+ implantation. Clinical results were assessed after 6 months to 3 years by clinical examination, Magee score and MRI. Good and very good clinical results were obtained and confirmed by MRI in 8 cases. In one case, cartilage hypertrophy was noted. There were no delamination and infection signs.
Jancewicz P, Mrozek T, Goralczyk A, Radziwon P, Rusak M, Chociej-Stypulkowska J Arthrosc Tech. 2022; 11(7):e1157-e1162.
PMID: 35936864 PMC: 9353078. DOI: 10.1016/j.eats.2022.02.025.
Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review.
Zhu Y, Fu W Front Bioeng Biotechnol. 2022; 10:956614.
PMID: 35935493 PMC: 9355401. DOI: 10.3389/fbioe.2022.956614.
Cell Sources for Cartilage Repair-Biological and Clinical Perspective.
Urlic I, Ivkovic A Cells. 2021; 10(9).
PMID: 34572145 PMC: 8468484. DOI: 10.3390/cells10092496.
Papadopoulos K, Turajane T Front Pharmacol. 2021; 12:652738.
PMID: 33959019 PMC: 8093874. DOI: 10.3389/fphar.2021.652738.
The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration : A Review.
Chen Y, Yan X, Yuan F, Ye J, Xu B, Zhou Z Front Pharmacol. 2020; 11:404.
PMID: 32308625 PMC: 7145972. DOI: 10.3389/fphar.2020.00404.